questions 1

Parkinson Disease

Topic updated on 09/19/17 4:41pm

  • A 63-year-old male is brought to the physician by his wife for the evaluation of a tremor. The tremor is worse at rest, and decreases in severity with purposeful movement. The patient reports to having difficulty with initiating voluntary movement, and his wife states that the patient’s movements have been slow. On exam, there is seborrheic dermatosis on the nasolabial folds. There is a “pill-rolling” resting tremor accentuated when the patient is asked to perform mental calculations. Resistance to passive movement at the elbow joint is noted. On gait testing, there was difficulty with initiating gait, as well as the patient taking short steps when walking forward.
  • Neurodegenerative progressive movement disorder
    • cardinal manifestations
      • tremor
        • resting, "pill-rolling"
      • bradykinesia
      • muscle rigidity
      • postural instability
    • associated with lewy bodies
  • Pathophysiology
    • neurodegeneration of dopaminergic neurons
      • e.g., substantia nigra pars compacta 
        • leads to bradykinesia due to distruption of basal ganglia circuit
      • may be related to failure of α-synuclein degeneration
        • major component of lewy bodies
          • intracellular eosinophillic inclusion
  • Secondary parkinsonism
    • loss or interference with the action of dopamine in the basal ganglia
    • due to idiopathic degenerative diseases, drugs, or exogenous toxins
      • drugs
        • methyl-phenyl-tetrahydropyridine (MPTP)
        • antipsychotics
        • reserpine
        • metoclopramide
      • diseases
        • frontotemporal dementia
        • lewy body dementia
      • others
        • carbon monoxide poisoning
  • Symptoms
    • motor involvement
      • resting pill-rolling tremor
      • bradykinesia
      • muscle rigidity
        • cogwheel rigidity
      • postural instability
      • shuffling gait
      • mask-like facies
    • depression
    • dementia
      • usually a late finding
  • Clinical diagnosis
  • Histology
    • loss of pigmented neurons in the substantia nigra
    • Lewy bodies
      • round eosinophilic inclusions of α-synuclein
  • Lewy body dementia
  • Alzheimer's disease
  • Essential tremor
  • Parkinson-plus syndromes
    • multiple system atrophy (Shy-Drager syndrome)
    • olivopontocerebellar atrophy
    • supranuclear palsy

  • Pharmacologic treatment
    • levodopa-carbidopa
    • dopamine agonist
      • pramipexole
      • bromocriptine
      • ropinirole
    • monoamine-oxidase type B (MAO-B) inhibitors
      • selegiline
    • amantadine
    • anticholinergics
      • benztropine
      • trihexyphenidyl
  • Surgical treatment
    • deep brain stimulation
    • thalamotomy
    • pallidotomy
Prognosis, Prevention, and Complications
  • Prognosis
    • a chronic progressive disorder
      • treatment improves quality of life and function
  • Prevention
    • currently not a preventable disease
  • Complications
    • dementia
    • depression
    • psychosis/hallucinations
    • pneumonia
      • most common cause of death


Qbank (0 Questions)

Sorry, this question is only available for Study Plan members.
Access to 600+ Questions not available in Free Qbank

Recent Videos

This video gives a description of the biological process of Parkinson's disease....

Evidence & References Show References

Topic Comments

Subscribe status: